According to GlobalData’s medical device pipeline database, eight Active Closure Devices devices are in various stages of development globally. GlobalData’s report provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, four are in active development, while the remaining four are in an inactive stage of development. All devices are in the late stages of development.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Active Closure Devices pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Active Closure Devices devices. Overall, most of these Active Closure Devices pipeline devices are being developed by private entities.
Key players involved in the active development of Active Closure Devices include Vivasure Medical, Aporo Biomedical, CardioDex, CPC of America and Dextera Surgical.
For a complete picture of the developmental pipeline for Active Closure Devices devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.